B-cell prolymphocytic leukemia causes: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 6: Line 6:
There are no established causes for B-cell prolymphocytic leukemia.
There are no established causes for B-cell prolymphocytic leukemia.


==B-cell prolymphocytic leukemia==
===Genetics===
There are no established causes for B-cell prolymphocytic leukemia.
*Genetic mutations like mutation or loss of p53 is thought to play a role.<ref name="pmid9058723">{{cite journal |vauthors=Lens D, De Schouwer PJ, Hamoudi RA, Abdul-Rauf M, Farahat N, Matutes E, Crook T, Dyer MJ, Catovsky D |title=p53 abnormalities in B-cell prolymphocytic leukemia |journal=Blood |volume=89 |issue=6 |pages=2015–23 |date=March 1997 |pmid=9058723 |doi= |url=}}</ref><ref name="pmid9058723">{{cite journal |vauthors=Lens D, De Schouwer PJ, Hamoudi RA, Abdul-Rauf M, Farahat N, Matutes E, Crook T, Dyer MJ, Catovsky D |title=p53 abnormalities in B-cell prolymphocytic leukemia |journal=Blood |volume=89 |issue=6 |pages=2015–23 |date=March 1997 |pmid=9058723 |doi= |url=}}</ref>
*11q23 and 13q14 deletions are associated with B cell prolymphocytic leukemia.<ref name="pmid1381952">{{cite journal |vauthors=Brito-Babapulle V, Ellis J, Matutes E, Oscier D, Khokhar T, MacLennan K, Catovsky D |title=Translocation t(11;14)(q13;q32) in chronic lymphoid disorders |journal=Genes Chromosomes Cancer |volume=5 |issue=2 |pages=158–65 |date=September 1992 |pmid=1381952 |doi= |url=}}</ref><ref name="pmid9595043">{{cite journal |vauthors=Solé F, Woessner S, Espinet B, Lloveras E, Florensa L, Pérez-Losada A, Vilà RM, Besses C, Sans-Sabrafen J |title=Cytogenetic abnormalities in three patients with B-cell prolymphocytic leukemia |journal=Cancer Genet. Cytogenet. |volume=103 |issue=1 |pages=43–5 |date=May 1998 |pmid=9595043 |doi= |url=}}</ref><ref name="pmid10360375">{{cite journal |vauthors=Lens D, Coignet LJ, Brito-Babapulle V, Lima CS, Matutes E, Dyer MJ, Catovsky D |title=B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene |journal=Leukemia |volume=13 |issue=6 |pages=873–6 |date=June 1999 |pmid=10360375 |doi= |url=}}</ref>
*t(11;14) translocation rembles the mutation of mantle cell lymphoma, which makes it harder for the clinicians to distinguish the two entities.<ref name="pmid15086413">{{cite journal |vauthors=Ruchlemer R, Parry-Jones N, Brito-Babapulle V, Attolico I, Wotherspoon AC, Matutes E, Catovsky D |title=B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia |journal=Br. J. Haematol. |volume=125 |issue=3 |pages=330–6 |date=May 2004 |pmid=15086413 |doi=10.1111/j.1365-2141.2004.04913.x |url=}}</ref><ref name="pmid24891323">{{cite journal |vauthors=van der Velden VH, Hoogeveen PG, de Ridder D, Schindler-van der Struijk M, van Zelm MC, Sanders M, Karsch D, Beverloo HB, Lam K, Orfao A, Lugtenburg PJ, Böttcher S, van Dongen JJ, Langerak AW, Kappers-Klunne M, van Lom K |title=B-cell prolymphocytic leukemia: a specific subgroup of mantle cell lymphoma |journal=Blood |volume=124 |issue=3 |pages=412–9 |date=July 2014 |pmid=24891323 |doi=10.1182/blood-2013-10-533869 |url=}}</ref><ref name="pmid26261659">{{cite journal |vauthors=Miao Y, Wang R, Fan L, Qiu H, Wu Y, Chen Y, Xu W, Li J |title=Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia |journal=Int J Clin Exp Pathol |volume=8 |issue=6 |pages=7494–8 |date=2015 |pmid=26261659 |pmc=4525993 |doi= |url=}}</ref>
*It can involve deletions from [[chromosome 11]] and [[chromosome 13]].<ref name="pmid10720137">{{cite journal |author=Lens D, Matutes E, Catovsky D, Coignet LJ |title=Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL) |journal=Leukemia |volume=14 |issue=3 |pages=427-30 |year=2000 |pmid=10720137 |doi=}}</ref>


==References==
==References==

Revision as of 20:20, 2 April 2019

B-cell prolymphocytic leukemia

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating B-cell prolymphocytic leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Biopsy

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

B-cell prolymphocytic leukemia causes On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of B-cell prolymphocytic leukemia causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on B-cell prolymphocytic leukemia causes

CDC on B-cell prolymphocytic leukemia causes

B-cell prolymphocytic leukemia causes in the news

Blogs on B-cell prolymphocytic leukemia causes

Directions to Hospitals Treating B-cell prolymphocytic leukemia

Risk calculators and risk factors for B-cell prolymphocytic leukemia causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Carlos A Lopez, M.D. [2]

Overview

There are no established causes for B-cell prolymphocytic leukemia.

Genetics

  • Genetic mutations like mutation or loss of p53 is thought to play a role.[1][1]
  • 11q23 and 13q14 deletions are associated with B cell prolymphocytic leukemia.[2][3][4]
  • t(11;14) translocation rembles the mutation of mantle cell lymphoma, which makes it harder for the clinicians to distinguish the two entities.[5][6][7]
  • It can involve deletions from chromosome 11 and chromosome 13.[8]

References

  1. 1.0 1.1 Lens D, De Schouwer PJ, Hamoudi RA, Abdul-Rauf M, Farahat N, Matutes E, Crook T, Dyer MJ, Catovsky D (March 1997). "p53 abnormalities in B-cell prolymphocytic leukemia". Blood. 89 (6): 2015–23. PMID 9058723.
  2. Brito-Babapulle V, Ellis J, Matutes E, Oscier D, Khokhar T, MacLennan K, Catovsky D (September 1992). "Translocation t(11;14)(q13;q32) in chronic lymphoid disorders". Genes Chromosomes Cancer. 5 (2): 158–65. PMID 1381952.
  3. Solé F, Woessner S, Espinet B, Lloveras E, Florensa L, Pérez-Losada A, Vilà RM, Besses C, Sans-Sabrafen J (May 1998). "Cytogenetic abnormalities in three patients with B-cell prolymphocytic leukemia". Cancer Genet. Cytogenet. 103 (1): 43–5. PMID 9595043.
  4. Lens D, Coignet LJ, Brito-Babapulle V, Lima CS, Matutes E, Dyer MJ, Catovsky D (June 1999). "B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene". Leukemia. 13 (6): 873–6. PMID 10360375.
  5. Ruchlemer R, Parry-Jones N, Brito-Babapulle V, Attolico I, Wotherspoon AC, Matutes E, Catovsky D (May 2004). "B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia". Br. J. Haematol. 125 (3): 330–6. doi:10.1111/j.1365-2141.2004.04913.x. PMID 15086413.
  6. van der Velden VH, Hoogeveen PG, de Ridder D, Schindler-van der Struijk M, van Zelm MC, Sanders M, Karsch D, Beverloo HB, Lam K, Orfao A, Lugtenburg PJ, Böttcher S, van Dongen JJ, Langerak AW, Kappers-Klunne M, van Lom K (July 2014). "B-cell prolymphocytic leukemia: a specific subgroup of mantle cell lymphoma". Blood. 124 (3): 412–9. doi:10.1182/blood-2013-10-533869. PMID 24891323.
  7. Miao Y, Wang R, Fan L, Qiu H, Wu Y, Chen Y, Xu W, Li J (2015). "Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia". Int J Clin Exp Pathol. 8 (6): 7494–8. PMC 4525993. PMID 26261659.
  8. Lens D, Matutes E, Catovsky D, Coignet LJ (2000). "Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL)". Leukemia. 14 (3): 427–30. PMID 10720137.